Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2000, p. 4337-4342, Vol. 38, No. 12
Department of Virology, Hellenic Pasteur
Institute, 11521, Athens,1 and
Department of Biology & Genetics, University of Thessaly
Medical School, Larisa 41222,2 Greece
Received 7 April 2000/Returned for modification 24 July
2000/Accepted 5 September 2000
The combination of preventive vaccination and diagnostic typing of
viral isolates from patients with clinical poliomyelitis constitutes
our main protective shield against polioviruses. The restriction
fragment length polymorphism (RFLP) adaptation of the reverse
transcriptase (RT)-PCR methodology has advanced diagnostic genotyping
of polioviruses, although further improvements are definitely needed.
We report here on an improved RFLP procedure for the genotyping of
polioviruses. A highly conserved segment within the 5' noncoding region
of polioviruses was selected for RT-PCR amplification by the
UC53-UG52 primer pair with the hope that it
would be most resistant to the inescapable genetic alteration-drift experienced by the other segments of the viral genome. Complete inter-
and intratypic genotyping of polioviruses by the present RFLP method
was accomplished with a minimum set of four restriction endonucleases
(HaeIII, DdeI, NcoI, and
AvaI). To compensate for potential genetic drift within the
recognition sites of HaeIII, DdeI, or
NcoI in atypical clinical samples, the RFLP patterns generated with HpaII and StyI as replacements
were analyzed. The specificity of the method was also successfully
assessed by RFLP analysis of 55 reference nonpoliovirus enterovirus
controls. The concerted implementation of these conditional protocols
for diagnostic inter- and intratypic genotyping of polioviruses was
evaluated with 21 clinical samples with absolute success.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Improved Genotyping Vaccine and Wild-Type
Poliovirus Strains by Restriction Fragment Length Polymorphism
Analysis: Clinical Diagnostic Implications
*
Corresponding author. Mailing address: Department of
Virology, Hellenic Pasteur Institute, 127 Vas. Sofias Ave., 11521 Athens, Greece. Phone: 30-1-64 47 959, ext. 274. Fax: 30-1-64 23 498. E-mail: vresearch{at}hol.gr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»